The Vanderbilt Institute of Chemical Biology's mission is to harness the power of chemistry to improve human health.
https://medschool.vanderbilt.edu/vicb/
VU Chemical Biology
Loading...
VICB member, Dr. James Crowe, was interviewed by @nytimes.com about the race to advance countermeasures for emerging infectious diseases.
Read more: news.vumc.org/2026/06/05/e...
TODAY is our next VICB Seminar featuring Clifton Barry III from the National Institute of Allergy and Infectious Diseases (NIAID).
📅 June 2 | 4 PM | 512 Light Hall
Co-hosted with VI4, Adult Infectious Disease, and the Tuberculosis Center at VUMC
"These resources have truly accelerated our research and helped expand its impact across multiple disease areas."
Thank you to Dr. Jerod Denton for highlighting the impact of VICB's HTS Facility and MDSC in advancing research discoveries.
@vubasicsciences.bsky.social
"These resources have truly accelerated our research and helped expand its impact across multiple disease areas."
Thank you to Dr. Jerod Denton for highlighting the impact of VICB's HTS Facility and MDSC in advancing research discoveries.
@vubasicsciences.bsky.social
The Vanderbilt Institute for Therapeutic Advances (VITA) is accepting applications for its inaugural funding program, supporting early-stage therapeutic discovery projects with awards of up to $350,000.
Applications are open through July 1.
Learn more: www.vanderbilt.edu/therapeutic-...
VU Chemical Biology
VICB member, Dr. James Crowe was recently featured in Nature discussing how promising antibodies discovered during a past #Ebola outbreak revealed opportunities for developing future therapies and strengthening outbreak preparedness.
bit.ly/4eebgEd
Preparing for future pandemics starts today.
VICB member, Dr. James Crowe highlights the need for proactive investment in antibody research and #pandemic #prevention strategies to address emerging viral threats before they become global crises.
🔗 news.vumc.org/2026/05/28/v...
🔬 #New Publications from VICB!
The latest publications span DNA repair, mitochondrial #biology, #neuroscience, #cancer #research, and #drug #discovery.
Explore the newest research: medschool.vanderbilt.edu/vicb/publica...
VICB member, Dr. James Crowe was featured in recent media coverage on #Ebola treatment and efforts to develop therapies for #hantavirus.
🔗 news.vumc.org/2026/05/28/n...
@vanderbilt.edu @vubasicsciences.bsky.social
VU Chemical Biology
VU Chemical Biology
Overview The Vanderbilt School of Medicine Basic Sciences fosters an environment where curiosity thrives, and scientists are empowered to contribute to the body of fundamental knowledge about human bi...
Less than one week away for our next VICB Seminar featuring Clifton Barry III from the National Institute of Allergy and Infectious Diseases (NIAID).
📅 June 2 | 4 PM
📍 512 Light Hall
Co-hosted with VI4, Adult Infectious Disease, and the Tuberculosis Center at VUMC
